Tech-Based Caregiver Support for Alzheimer's Disease
(TACAD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of the proposed study is to preliminarily evaluate Technology-based information and coaching/support program that is tailored for Asian American midlife women who are family caregivers of patients living with Alzheimer's disease (TACAD) in improving health outcomes of Asian American midlife women who are family caregivers of persons living with Alzheimer's disease (AACA) and their care recipients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is the tech-based caregiver support for Alzheimer's disease safe for humans?
The studies reviewed focus on the feasibility and acceptability of caregiver interventions, but they do not provide specific safety data for the tech-based caregiver support. However, caregivers who participated in these interventions found them informative and engaging, suggesting they were generally well-received.12345
How is the TACAD treatment different from other Alzheimer's disease treatments?
TACAD is unique because it is a technology-based program specifically designed to support Asian American midlife women who are family caregivers of Alzheimer's patients, focusing on culturally-responsive education and coaching to help them manage the complex and unpredictable nature of the disease.14678
What data supports the effectiveness of the treatment Tech-Based Caregiver Support for Alzheimer's Disease?
Research shows that internet-based support services for Asian American caregivers, like the one developed for Chinese caregivers, are feasible and can improve caregivers' knowledge and self-efficacy in seeking support. Additionally, a pilot intervention for Vietnamese American caregivers was well-received and led to increased Alzheimer's knowledge and confidence in accessing support services.1491011
Who Is on the Research Team?
Eun-Ok Im, PhD, MPH
Principal Investigator
University of Texas at Austin
Are You a Good Fit for This Trial?
This trial is for Asian American women, aged 40-65, who are Chinese or Korean and care for family members with early to middle-stage Alzheimer's. They must read/write English, Mandarin, or Korean, live in the U.S., have internet access, and provide at least 4 hours of daily unpaid care without plans for institutionalizing the patient within six months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a technology-based program for 3 months, with weekly group and individual coaching/support for the intervention group.
Follow-up
Participants are monitored for changes in caregiver and care recipient outcomes through Internet surveys.
What Are the Treatments Tested in This Trial?
Interventions
- Alzheimer's Association website
- TACAD
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor
Emory University
Lead Sponsor